RecallRadar

FDA Drug recall D-0355-2020

Polycin (bacitracin zinc and polymyxin B sulfate) Ophthalmic Ointment USP, Net

On 2019-11-27 the FDA classified a Class II recall of Polycin (bacitracin zinc and polymyxin B sulfate) Ophthalmic Ointment USP, Net by Altaire Pharmaceuticals, citing lack of Assurance of Sterility.

Read the official FDA Drug notice

AgencyFDA Drug
Recall numberD-0355-2020
ClassificationClass II
Statuscompleted
Initiated2019-07-02
Published2019-11-27
Last updated2026-09-13 11:52 UTC
CompanyAltaire Pharmaceuticals
DistributionUS

Product

Polycin (bacitracin zinc and polymyxin B sulfate) Ophthalmic Ointment USP, Net. Wt. 3.5 g (1/8 oz.), Rx only, Manufactured for Perrigo, Minneapolis, MN 55427, NDC 0574-4021-35

Reason

Lack of Assurance of Sterility

Identifiers

code_info
Lot#: RGD, Exp 7/19; RHL, Exp 8/19; RHB, Exp 9/19; RJF, Exp 10/19; RJG, Exp 10/19; SAJ, Exp 1/20; SAK, Exp 1/20; SAL, E…Lot#: RGD, Exp 7/19; RHL, Exp 8/19; RHB, Exp 9/19; RJF, Exp 10/19; RJG, Exp 10/19; SAJ, Exp 1/20; SAK, Exp 1/20; SAL, Exp 1/20; SAM, Exp 1/20; SBK, Exp 2/20; SEH, Exp 5/20; TCD, Exp 1/21

Status history

No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: completed.

Source

Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0355-2020%22

RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.